🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Adjuvanted influenza vaccine

Found 271 matching trials

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

PHASE2

Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...

Status

Completed

Location

Radboud University

Start Date

2021-09-20

Trial ID

NCT05082688

Treatments Being Tested

Herpes zoster vaccination (Shingrix, GSK)Influenza Vaccine (Fluarix Tetra Northern Hemisphere 2021 or 2022, GSK)Placebo

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

PHASE3

The aim of this study is to assess the immunogenicity, safety and reactogen...

Status

Completed

Location

GSK Investigational Site

Start Date

2022-10-14

Trial ID

NCT05568797

Treatments Being Tested

RSVPreF3 OA vaccine FLU vaccine

Non-specific Response to H1N1 Vaccine

N/A

This is a prospective observational study with recruitment of healthy volun...

Status

Completed

Location

University Clinic of Respiratory and Allergic Diseases

Start Date

2009-11

Trial ID

NCT01178918

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

PHASE4

The purpose of this study is explore the antibody and cell mediated immune ...

Status

Completed

Location

Azienda Ospedaliera Universtaria Senese

Start Date

2009-12

Trial ID

NCT01079273

Treatments Being Tested

egg-derived A/H1N1 pandemic influenza vaccine

A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season

PHASE4

A study to evaluate the humoral immune response 3 weeks after vaccination w...

Status

Completed

Location

Dept. of Health Sciences, University of Genoa and Hygiene Unit, "San Martino" University Hospital

Start Date

2011-10

Trial ID

NCT01457027

Treatments Being Tested

Inflexal V

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

PHASE2

The purpose of this study is to evaluate the immunogenicity and the safety ...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-10-20

Trial ID

NCT00385840

Treatments Being Tested

Influenza Vaccine GSK1247446A FluarixTM

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

PHASE2

The purpose of this Phase II follow-up study (to study 810501) is to assess...

Status

Completed

Location

University Hospital, Department of Clinical Pharmacology, General Hospital Vienna

Start Date

2007-09

Trial ID

NCT00530660

Treatments Being Tested

H5N1 influenza vaccine (whole virion, Vero cell-derived), 7.5 µg HA antigen, non-adjuvanted

A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

PHASE2

"Multimeric-001" (M-001) has been recently developed, containing conserved,...

Status

Completed

Location

Hadassah medical center

Start Date

2011-08

Trial ID

NCT01419925

Treatments Being Tested

Two Multimeric-001 administrations followed by TIV One administration of Multimeric-001 followed by TIV One administration of adjuvanted M-001 followed by TIV One administration of placebo followed by TIV

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

PHASE1

Based on pre-clinical trial data and principle of GCP, the objective of pha...

Status

Completed

Location

China-Japan Friendship Hospital

Start Date

2005-12

Trial ID

NCT00356798

Treatments Being Tested

an inactivated whole virion H5N1 vaccine, adjuvanted

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

PHASE3

The primary purpose of this study is to demonstrate the efficacy of an inve...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00566345

Treatments Being Tested

Inactivated seasonal influenza vaccine (split virus, Vero cell-derived)Phosphate buffered saline

Previous Next